Veterinary Medicines

Trivacton

Not authorised
  • Bovine coronavirus, strain CR1, Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotypes O117 and O8 (antigen Y), Inactivated
  • Escherichia coli, serotype O78 (antigen 31A), Inactivated
  • Escherichia coli, serotype O101 (fimbrial adhesin F41), Inactivated
  • Bovine rotavirus A, strain RoI, Inactivated
Download as PDF

Product identification

Medicine name:
Trivacton
Active substance:
  • Bovine coronavirus, strain CR1, Inactivated
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotypes O117 and O8 (antigen Y), Inactivated
  • Escherichia coli, serotype O78 (antigen 31A), Inactivated
  • Escherichia coli, serotype O101 (fimbrial adhesin F41), Inactivated
  • Bovine rotavirus A, strain RoI, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine coronavirus, strain CR1, Inactivated
    1.50
    log10 serum neutralising unit(s)
    /
    5.00
    millilitre(s)
  • Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
    1.30
    log10 slow agglutination unit(s)
    /
    5.00
    millilitre(s)
  • Escherichia coli, serotypes O117 and O8 (antigen Y), Inactivated
    0.90
    log10 slow agglutination unit(s)
    /
    5.00
    millilitre(s)
  • Escherichia coli, serotype O78 (antigen 31A), Inactivated
    1.50
    log10 slow agglutination unit(s)
    /
    5.00
    millilitre(s)
  • Escherichia coli, serotype O101 (fimbrial adhesin F41), Inactivated
    0.60
    log10 slow agglutination unit(s)
    /
    5.00
    millilitre(s)
  • Bovine rotavirus A, strain RoI, Inactivated
    2.00
    log10 haemagglutination inhibiting unit(s)
    /
    5.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 520a/91
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 29/03/2022
Download